Nevro Q2 2024 GAAP EPS $(0.53) Beats $(0.68) Estimate, Sales $104.161M Miss $107.347M Estimate
Portfolio Pulse from Benzinga Newsdesk
Nevro (NYSE: NVRO) reported Q2 2024 GAAP EPS of $(0.53), beating the estimate of $(0.68) by 22.06%. However, sales of $104.161 million missed the $107.347 million estimate by 2.97%, marking a 4.27% decrease from the same period last year.
August 06, 2024 | 8:42 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Nevro's Q2 2024 earnings per share beat expectations, but sales missed estimates and declined year-over-year. This mixed performance may lead to short-term volatility in the stock price.
While Nevro's EPS beat expectations significantly, the miss on sales and the year-over-year decline in revenue could create mixed sentiment among investors. This is likely to result in short-term volatility as the market digests the mixed results.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100